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Abstract
Background: Unsatisfactory colposcopy, where the cells of interest are not visible in women with a positive cervical
screening test, is a common area of clinical uncertainty due to the lack of clear evidence and guidance. Colposcopists’
opinions and experiences are likely to have a significant influence on service provision and the development of national
policy. The aim of this study was to analyse decision-making when applied to women with unsatisfactory colposcopy.
Methods: A multi-centre qualitative study utilizing a series of focus groups in an English healthcare region.
Sampling aimed to ensure heterogeneity of experience and healthcare provider demographics. A topic guide
covered a range of clinical and cytological variables and was compiled by the researchers and three expert
Colposcopists. Using an iterative approach, thematic analysis was selected as the most appropriate method to
identify factors affecting decision-making.
Results: Twenty-three Colposcopists from four units participated. The decision to treat was easier in women
with high-grade cytology and high risk women with low-grade cytology such as heavy smokers, poor
attenders, older women, those who had completed their families and women opting for treatment. Where
decision-making was more complex, intuition and a multi-disciplinary approach were used to guide
management. Areas of dissonance, which are affected by paucity of evidence and emotive factors, included
cytological collection device, clinical setting and length of conservative follow-up and depth of excision in
women at high risk of treatment-related morbidity.
Conclusions: Anxiety of missing a cancer deters long-term cytological follow-up, resulting in heterogeneity of
care and higher than anticipated excisional treatments in women with low-grade screening and unsatisfactory
colposcopy. In areas of clinical uncertainty when decisions are dominated by affect, clinical guidance can reduce the
difficulty and anxiety of decision-making.
Keywords: Unsatisfactory colposcopy, Attitudes, Decision-making, Clinical uncertainty
Background
Persistent infection with Human Papillomavirus (HPV)
causes 99% of cervical cancers [1]. In the UK, primary
HPV screening was instituted in six ‘sentinel sites’ in 2011
(including Bristol) and the high negative predictive value
of this test (>99%) [2] has led the NHS Cervical screening
programme to recommend replacement of the current
HPV triage of low-grade cytology with HPV primary
screening. The screening sample will initially be tested for
one of the 30 high risk HPV subtypes and if positive, a
woman’s risk of pre-cancerous change will be triaged into
low-grade or high-grade by a cytology test. This result
helps to stratify who may require treatment; with a HPV
positive, high-grade cytology result there is an 82% chance
that the excised tissue will contain high grade pre-
cancerous cells and a 2.6% chance of cancer. With a HPV
positive, low-grade cytology result, this risk is 15.9% and
0.1% respectively [3].
However, a positive screening result is not a definitive
determinant of outcome. The positive predictive value
(PPV) of detecting CIN2+ in women who have high risk
HPV and low-grade cytology is only 16% [2]. 80% of
immunocompetent women will clear a HPV infection [4]
and the low PPV indicates that HPV testing currently fails
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to differentiate between these women and the 20% who
will have persistent infection.
Therefore, women with a positive cervical screening
test are referred to the colposcopy clinic. The purpose of
this assessment is to visualise the area infected by HPV
and determine who requires treatment and who can be
managed with conservative cytological follow-up. Man-
agement difficulties arise when the cells of interest are
‘tucked inside’ the cervix and are not visible for assess-
ment. This is known as unsatisfactory colposcopy or a
transformation zone (TZ) type 3, the incidence of which
is approximately 20% [5], potentially accounting for
34,555 of the 172,776 women reviewed in Colposcopy
each year [3]. The identification of a TZ type 3 and the
inability to provide histological selection for treatment
may deter cytological follow-up and lead to higher
rates of excisional treatments in women with low-
grade screening results [6] to prevent missing a ‘hid-
den’ cancer.
The quandary for Colposcopists is the treatment re-
lated morbidity as a deeper excision (15-25 mm) is
recommended in this cohort [7]. This treatment can
increase the risk of preterm birth [8] and cervical
stenosis which in turn can lead to infertility and diffi-
culty with future cytological assessments [9, 10]. Fur-
thermore, there is an 8.6 fold increased risk that the
excised tissue will be normal when compared to exci-
sions where the cells of interest are visible [6]. It seems
clear that a reduction in unnecessary treatments is needed
to improve patient outcomes.
Currently, guidance for cytological follow-up versus
excisional treatment is hospital specific [5, 7, 11] in
this cohort and this may lead to disparities in care.
Attendance rates for colposcopy and loss of patients
to follow-up has been shown to be affected by service
inefficiencies [12], anxiety [13, 14] and poor accessibility
to targeted information [15, 16]. With non-attendance
rates for colposcopy in the UK documented at 24.4%, of
which 46.1% are follow-up appointments [17], areas of
heterogeneity in service provision need to be improved.
Clinical decision-making is a complex process and the
inconsistent nature of intuitive management has led to
the development of evidenced based practice [18] which
aims to minimise morbidity and maximise optimal out-
comes. However, when a paucity of evidence exists,
decision-making under conditions of uncertainty can be
influenced by patient choice or demographics and health
care provider attitudes, experience, age, gender or cul-
ture [19, 20]. Colposcopists play an important role in
leading research and policy change in cervical screening
programmes and there is currently no literature to
suggest how their opinions and experiences shape the
management or counselling of these patients. The aim
of this study was to identify factors that affect
Colposcopist’s decision-making, specifically recom-
mendations for excisional treatments over cytological
follow-up, and to interpret these findings in line with
decision-making theory.
Method
This was a qualitative study, utilising a series of focus
groups. Colposcopists working in NHS trusts within the
South West of England Region were purposively sampled
to achieve maximum variation [21]. Participants were
included if they were active accredited members of the
British Society for Colposcopy and Cervical Pathology
(BSCCP); membership is a pre-requisite to practice as a
Colposcopist as the BSCCP standardises training and
audits quality of service provision. In two waves of recruit-
ment, lead Colposcopists from each trust (who are re-
sponsible for quality assurance) were contacted by email.
They forwarded the study information to all Colposcopists
within the unit to request participation. Prior to taking
part in the focus groups, Colposcopists’ provided written
consent to participate, to be audio-recorded and for anon-
ymised quotes to be utilised in publications.
Sampling aimed to ensure heterogeneity, such that a
range of demographics and opinions were included to
improve the generalisability of the findings. Data regarding
years of experience in colposcopy and job title were col-
lected. Different health care professionals such as nurses,
oncologists, family doctors and general gynaecologists can
accredit as Colposcopists; their background experience may
shape their attitudes and opinions and affect the decisions
they make. Protocols and educational experience may vary
in different units and therefore demographic location of the
Colposcopists’ training centre was also collected. To main-
tain anonymity, age and gender were not collected. Data
saturation [22], such that no new opinions or attitudes were
identified, was achieved with a total of twenty-three Col-
poscopists from four centres. At this point, recruitment
ceased.
A topic guide (Table 1) was designed by qualitative and
clinical researchers in collaboration with three experts in
the field (who did not participate in the focus groups). An
expert was defined as a Colposcopist who was respected
and nominated by their peers for their expertise in colpos-
copy, as these practitioners manage complex as well as
routine cases. The topic guide consisted of open questions;
these aimed to focus the discussion and allow an explor-
ation of the decisions that are made when reviewing
women with unsatisfactory colposcopy and a range of clin-
ical and cytological variables. These questions focused on
length, clinical setting and technique of follow-up, the
depth of excision undertaken in relation to patient and clin-
ical characteristics and how Colposcopist’s practice is influ-
enced by the current literature and guidance. These semi-
structured focus groups enabled the researcher to cover the
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core set of questions and allow a flexible and dynamic
discussion that could be led and expanded upon by the par-
ticipants. To understand the Colposcopists’ decision-
making process, participants were asked to identify the cri-
teria they used in management decisions by asking ‘why’
and ‘how’.
A researcher (KM, who is an accredited Colposcopist
and trained in qualitative research methodology) conducted
the focus groups. Due to the amount of technical content,
the challenge of conducting these discussions was reduced
by KM being a Colposcopist. A facilitator (SP or RB) were
present to aid transcription by recording the speaker order,
noting non-verbal communication and assisting in further
exploration of raised points. The focus groups were com-
posed of staff from each individual trust (block sampling),
conducted in private rooms at the participants’ hospital
and lasted 40–50 mins. Refreshments were provided to fa-
cilitate participation during Colposcopists’ lunch times.
Field notes were written immediately after the focus group
to aid in the interpretation of the transcripts and context-
ualise the discussion. Interviews were transcribed (by KM)
with the aid of the speaker list. All participants were anon-
ymised and the transcripts sent to respondents and the
facilitator (SP/RB) for validation. One participants’
statement was refined to expand upon how their anxiety
of missing a cancer affected their decision-making, but
this did not lead to the researchers disregarding their in-
terpretation of the data. The qualitative software package
NVivo 10 was used to aid analysis.
Thematic analysis (TA) was selected as the most appro-
priate method for this study; it is one approach that can be
used to identify, analyse and organise patterns of opinions
within a data set. We chose this method as the experiences
of participants can be analysed without evaluating how they
experience reality (such as with IPA or phenomenology). It
also provides the flexibility to allow participants to expand
upon their worries and interests without deviating from the
decision-making process (which was the aim of this study).
TA was chosen in preference to grounded theory as data
was collected through the use of focus groups and the focus
was not on social processes [22, 23]. Data was inductively
coded, using the six stage TA process described by Braun
and Clarke [24]; as outlined below.
In an iterative process, analysis was conducted after each
interview so that future focus group questions were in-
formed by prior analysis [22]. After familiarisation with the
data and discussion between the researchers, a coding list
was developed and the first transcript individually coded by
three researchers (KM, RS, RB). RB and RS are postdoctoral
qualitative researchers who are affiliated with the University
of Bristol and have no clinical involvement in the Colpos-
copy units that were approached. The data informed the
coding, rather than using a rigid pre-designed coding struc-
ture or framework of behavioural determinants, to reduce
the chance of the researcher’s pre-conceived ideas affecting
the themes that were identified in the data set. The coding
framework was then applied to future transcripts and
revised once more as further transcripts were analysed. To
achieve a rigorous analysis, consistency of interpretation
was assessed: Two research members (KM and RS) inde-
pendently coded the last three transcripts, results were
compared, divergences discussed and disagreements settled
by a third researcher (RB). Field notes were compared with
the transcripts to define tone and potential meaning of the
words transcribed.
On completion of the coding, all researchers met to
discuss and refine key themes that were described in the
data. Themes were then defined following in-depth con-
sideration of potential alternative interpretations through
the use of mind maps and iterative lists. In a semantic
approach, illustrative quotes, descriptive accounts and
tables of the themes were then developed from the data. A
framework of decision-making was developed after a
literature search and brainstorming. Themes that were
identified within the data were then mapped to the rele-
vant theoretical constructs within this framework.
Results
Twenty-three of a potential twenty-eight Colposcopists
from four units participated in four focus groups. The
Colposcopists who declined gave conflict with their clin-
ical workload as the reason for non-participation. The
participants represented a range of years of experience,
geographical training backgrounds and specialty. There
were five nurse practitioners, four gynaecological oncolo-
gists, three lead Colposcopists, seven gynaecology consul-
tants, two pathologists and two gynaecology registrars.
Years of experience in colposcopy ranged from 1 to 34 with
Table 1 Focus Group Topic Guide
Unsatisfactory Colposcopy Topic Guide
Conservative management
- Why
- Effect of age
- Effect of parity
- Effect of HR HPV
- Length of follow up
- Place of follow up
- Technique of follow up (what)
Depth of LLETZ
- How deep?
- Why?
- Who?
- Alternative methods of
treatment
Who to treat?
- How
- Where
- Why
- Effect of age
- Effect of parity
- Effect of HR HPV
Quality monitoring
- Reporting methods
- Interpreting the reports
- HPV education of
colposcopists
Oestrogen
- Who?
- How?
- Alternative uses
- Other methods of everting the TZ?
Issues regarding colposcopy
management
- National guidance
- Patient focused.
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the mean number of years 11.2. Fourteen participants
trained in the South West region of the UK, three in
London, two in the West Midlands, two in the Northern re-
gion, one in the North East and one in the Eastern region.
Two of the units were included in the sentinel sites study
and had eight years of experience in managing women
referred with HPV triage of low-grade cytology and three
years of experience with primary HPV testing prior to this
study’s data collection. The remaining two units had two
years’ experience of HPV triage of low-grade cytology
following the national roll-out in 2013. Four key themes
which affected decision-making were identified;
Theme 1: anxiety of missing cancer
Lack of confirmatory histology
In our study, irrespective of a high-grade or low-grade
result, if the cells of interest were not visible and a diag-
nostic biopsy was not possible, most participants were
deterred from advocating long-term cytological follow-up.
01: ‘They’ve come to colposcopy and it’s been
pointless because you’re not getting the information
you want from that examination. Yes, there is a good
chance it could clear up but I just feel a bit nervous
about leaving them because there could be high grade
there that you can’t see...It’s knowing whether it’s
there or not, that’s the nightmare.’
This suggests an affective component to decision-
making; fear of missing high-grade disease induces a pes-
simistic outlook of future events if women are not offered
an excisional treatment. It appears that this is of higher
importance than concerns relating to treatment morbidity,
even in women with a low-grade cytology result.
Impact of a high-grade cytology result
In these women the majority of participants strongly ad-
vised, with patient consent, an excisional treatment irre-
spective of age or family status. Affect and cognition had
a major influence on decision-making; anxiety of missing
a cancer if treatment was not undertaken was driven by
the plethora of evidence which shows there is a signifi-
cant risk of the excised tissue containing high-grade pre-
cancerous cells. When making decisions that could
result in dangerous outcomes and negative emotions,
participants made safe choices.
02: ‘If you think of these women having a cancer,
there’s a cancer that we just can’t see, it’s tiny, it’s
inside the canal. If you repeat the cytology and you
are giving it at least three months, then we don’t
know if those three months could make a 1a1 (Cancer
grading) into a 1a2 or even a 1b1 - who knows that?
So that’s my worry, I look at what’s the worst possible
scenario here and with high grade cytology it’s more
than likely that there will be high grade disease inside.’
Theme 2: the screening test result
A HPV positive status increases the risk of treatment
Although Colposcopists did not reflect on the global
impact of HPV testing within colposcopy, they did discuss
how a high risk HPV result in conjunction with low-grade
cytology would affect their decision-making. Sixteen Col-
poscopists suggested that a high risk HPV result increased
the chances of a woman having underlying high-grade
disease. This belief appeared to reduce the uncertainty in
their decision-making as all participants agreed that this
perceived increase in risk, with the potential of missing a
cancer, was leading to higher rates of excisional treatments
in this cohort.
22: ‘I think, in the younger ones, how long do you
wait to see if the HPV is going to resolve? And I think
that now we are using HPV testing that has upped the
ante. So you know that they’ve still got active HPV
and the longer that stays the more likely they are to
have an abnormality. So I do talk to them about
having a LLETZ (excisional treatment).’
07: ‘I think, you know, the sensitivity has gone up and
you do see high-grade histology with low-grade
smears...and I would probably, in the older women, I
would be much more pushed to do just a small LLETZ.’
Colposcopists appear to be highly risk adverse and
choose, what they view, as the least dangerous outcome
i.e. treatment morbidity over the chance (even if small)
of missing a cancer. Being ‘pushed’ into advocating a
treatment suggests they would have preferred to manage
women with low-grade screening results more conserva-
tively but worried about the potential risks of doing so.
Pathologists and lead Colposcopists (who are responsible
for quality assurance) suggested that Colposcopists’ be-
haviour was shaped by their experience of reviewing
women with a positive HPV result. Rather than recog-
nising the benefits of an improved screening test, they
suggested other Colposcopists felt women were at in-
creased risk of high-grade disease and this conferred the
belief that conservative follow-up was a riskier choice.
14: ‘There is a shift in expectations and opinion
rather than pathology.’
21: ‘What you’re doing is weeding out the women
with borderline or low-grade smears who have no
pathology because they are HPV negative...a patient
who has a mild smear with HPV positive is at no
greater risk than they were 10 years ago.’
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Theme 3: patient characteristics
Stratifying risk factors for high-grade disease
When patients present with individual characteristics
known to increase the risk of cancer such as smoking, poor
attendance, older age and / or increased parity, behavioural
decision-making is influenced by analytical thinking. Ra-
tional judgement denoted that in women with low-grade
screening, the decision to treat was easier if women were
stratified as high-risk - the possibility of developing a cancer
outweighed the risk of treatment-related morbidity.
14: ‘If she’s a heavy smoker and she’s clearly never
going to give up, then that predisposes me towards
treatment...’
04: ‘...I think you’re going to be more likely to do a
small LLETZ (excisional treatment) on someone
you’re going to be concerned about their attendance.
It’s an individual thing.’
01: ‘If she had had her family or was an older lady, I
would do a loop (excisional treatment) for diagnosis.’
A multi-disciplinary approach
Young women who have not started their families and
present with low-grade cytology and risk-adverse behav-
iour are at low-risk of high-grade dysplasia but high risk
for treatment related morbidity. A multi-disciplinary ap-
proach was advocated by fourteen colposcopists in three
focus groups for these women.
13: ‘A young nulliparous woman I would bring to the
MDT to get a consensus that it was the right thing to
do a LLETZ (excisional treatment), to be honest, in
case they have problems in the future. If it was an
MDT decision I’d feel happier.’
This suggests participants are concerned that their affect
is influencing their rational thinking and by sharing
decision-making with an expert group they assuage this
emotional response. The participants who advocated the
MDT suggested this choice was influenced by the introduc-
tion of HPV screening. They indicated this had resulted in
women being referred to colposcopy earlier, reducing the
time needed to clear the infection and subsequently
increasing the chance of over-treatment. Cognition (their
knowledge of the natural history of HPV infection) and
intuition (prior experience of reviewing women pre- and
post-HPV screening) appears to affect behaviour.
16: ‘We’re treating them sooner because they are
coming to us sooner.’
14: ‘But that’s a potential disadvantage isn’t it....?’
16: ‘Not if there’s high grade in it.’
14: ‘But, we might be over-treating the women who
potentially might get better.’
17: ‘CIN2 (pre-invasive disease) in a young girl has a
40% chance of regression, doesn’t it.’
Patient choice
This was discussed as a major factor in decision-making
in all of the focus groups. Colposcopists acceded to
patient treatment wishes, even in women at high risk of
treatment morbidity and low risk of disease, if the
woman was informed of and understood the potential
risks of their chosen management option. This suggests
that cognitive factors influencing Colposcopist’s
decision-making can be superseded by the patient’s
affect and cognition.
03: ‘You know, it’s a discussion with the patient
explaining the pros and cons”.
17: “I had a woman the other day, actually, who wanted
a LLETZ (excisional treatment). Her mum died of
cervical cancer, she actually had a low grade smear,
but she said ‘just cut it away’. I was like ‘but you’re 25,
let’s just do a couple of smears’ and she said ‘just cut it
away’. So I spoke to the consultant on call and they
said ‘do what the patient wishes’”.
None of the participants mentioned scenarios in which
women had declined treatment and the subsequent impact
of this choice.
Theme 4: paucity of guidance engenders reliance on
clinical experience
Clinical setting for cytological follow-up
In women with low-grade screening results who were
deemed suitable for cytological follow-up, there was a lack
of consensus regarding where to review them. Eight par-
ticipants (including four of the five nurse Colposcopists)
advocated GP (family doctor) follow-up.
09: ‘If they’ve got abnormalities already on the current
smear, there’s no good reason why you should have to
bring them back to colposcopy. If it was a low grade
smear I would probably send her back to her GP
because we’ve got direct referral to colposcopy and we
all use the same lab.’
This suggests trust in the reliability of the laboratory and
a belief that outcomes will be the same in the community
and the hospital as smear technique is standardised.
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Conversely, fifteen colposcopists, who were all doctors,
differed in this opinion:
12: ‘I hear what you’re saying about having a good
reliable lab but patients aren’t often very reliable and
so I’d like to know that she’s been followed up and
make efforts to do so.’
07: ‘We haven’t made the diagnosis yet, she still sort
of belongs to us. We can’t discharge her to the
community without working out whether there is
something to get concerned about or not.’
The doctors suggested they had a responsibility to
ensure a decision / diagnosis was made and a cancer not
missed by personally reviewing these women. Doctors
tend to review more complex cases and the adverse out-
comes of missed diagnosis. This may have influenced their
management choice. It appears that emotion can be more
influential that cognitive elements when the risk of cancer
is factored into decision-making. The role of emotion and
responsibility was strengthened by the paucity of guidance
surrounding the optimal technique of taking a smear in
women with unsatisfactory colposcopy.
17: ‘They don’t do endocervical smears (in the
community) so how can you specify that? You see I
would do a cytobrush and broom. With a type 3
transformation zone you’re more likely to get a better
specimen with a brush and broom, aren’t you?’
14: ‘I agree with you, but has anyone proven that.’
17: ‘No, not that I know of.’
It appears that in conditions of clinical uncertainty, in-
tuitive decision-making - affect, perception, rational
judgement and prior experience – aids Colposcopists in
assessing risk.
Length of cytological follow-up
For those women whom participants recommended
cytological follow-up rather than excision, there was a
discrepancy in the number of months advocated before
repeating the smear. Thirteen colposcopists suggested
six months and if at this time, any grade of cytological
abnormality was reported and the examination was still
unsatisfactory, they would recommend an excision.
16: ‘I would prefer to see them in 6 months. They’ve
come to colposcopy and it’s been pointless because
you’re not getting the information you want from that
examination. Yes, there is a good chance it could clear
up but I just feel a bit nervous about leaving them
because there could be high grade there that you can’t
see.’
03: “…I do think it’s kind of two strikes and you’re
out, the referral cytology and a 6 month follow up,
because they clearly still have got continuing HPV”.
This suggests an affective component to decision-
making; anxiety about missing high-grade disease, com-
pounded by the perceived risk that persistent HPV
confers, deterred long-term follow-up even in women
with low-grade screening. Conversely, six colposcopists
discussed individualising care based on patient risk fac-
tors. If women were young and/or nulliparous with low
risk factors, participants recommended a 12 month cyto-
logical follow-up.
09: ‘The 12 month repeat allows the immune system
to battle HPV, as studies showed there is a greater
clearance at 12 months rather than 6 months.’
14: ‘The debate we’re having here is whether 6 months
or 12 months is better and the issue or question is
whether this lady might have a high grade dysplasia
underlying. The likelihood of that becoming a
malignancy in the 6-12month phase is (pause) in the
order of a fraction of a percent.’
This suggests a combination of cognitive and intuitive
decision-making based on prior experience, perception
of risk and knowledge.
Repetition of the referral cytology
Two of the Colposcopists who could not attend the focus
groups provided the researchers with a scenario they con-
sidered an area of clinical uncertainty; due to the topo-
graphic position of the TZ, would Colposcopists repeat
the referral cytology at the first colposcopy appointment?
The majority of the Colposcopists adhered to national
guidance and did not repeat the smear. However, some
participants suggested they had concerns that the referral
cytology collection device may not have adequately sam-
pled the TZ due to its endocervical position.
01: “I think if we speak to any cytologist they’ll always
say you should not repeat the smear within 8 weeks
because you’ve already sampled it and you’ve already
taken off the epithelium and then you really need to
wait for it to re-grow or you’re going to get a false
positive / false negative and you’re going to be back to
square one”.
16: “I would wait three months. I know not everybody
does”.
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17: “If it was a poor sample with a TZ3 then I would
re-smear”.
Oestrogen use is based on prior experience
The use of oestrogen has been discussed in the literature as
a potential pharmacological method which can convert
unsatisfactory colposcopy to satisfactory. Colposcopist’s dis-
cussed their recommendations for its use which appeared
to be linked to prior experience.
12: ‘The thing with oestrogen is you’re never too sure
about the compliance prior to it and whether that
makes a difference.’
01: ‘If she has an atrophic cervix I would ask her,
definitely, to have two weeks of oestrogen before her
next cytology...not so much because you’re going to
pull out the transformation zone but, it can help
the interpretation of the cytology. Also for her
comfort...’
For this intervention, it appears that intuition plays a
greater role than cognition. Despite the evidence suggesting
the potential benefits of use the majority of participants felt,
in practice, it did little to improve the examination findings.
The majority of gynaecological oncologists did not advocate
use but eleven participants, including all of the nurse
colposcopists, prescribed oestrogen to improve the smear
quality and reduce discomfort during the examination. Gy-
naecological oncologists manage women with oestrogen
driven cancers and this may have affected their decision-
making, particularly as they reported no real improvement
in examination adequacy and therefore the harm of
oestrogen use may have outweighed the benefit in their
minds. Three of the four units used topical preparations
and the reasons identified were the side effect profile and
poorer efficacy of systemic hormone replacement therapy.
As with seen in theme one, negative emotions led partici-
pants to make, what they considered to be, the safer man-
agement options.
06: ‘Well I guess topical oestrogens are less harmful
than actually giving HRT...and it works.’
Depth of excisional treatment (LLETZ)
Decision-making in this area was driven by prior experi-
ence, perceived individual risk and affect.
14: ‘Greater than 7 less than 10mm to reduce the risk
of cervical dysfunction in pregnancy.’
07: ‘There’s a chance there’s absolutely nothing wrong
with her cervix and you’re chucking out a big bit of
tissue and if you do really have something wrong with
the cervix there’s the option of doing a second LLETZ
if you’re really concerned.’
02: ‘I think the biggest problem is that because you
can’t see the TZ (cells of interest) you don’t know
how far to go...If you do a deeper loop and it is
negative that is much easier to criticise than if you do
a smaller loop and then if it is positive, you do
another one because that is much more targeted.’
As seen in theme one and with systemic oestrogen use,
Colposcopists make safe choices. Women at high-risk of
treatment related morbidity engender negative emotions
which prompted participants to make autonomous
choices and deviate from UK national recommendations
for optimal depth (15-25 mm) [7]. In older woman, who
are at reduced risk of treatment morbidity and increased
risk of high grade disease, Colposcopists adhered to na-
tional guidance. Cognition and rational judgement had a
greater impact than affect in this patient demographic.
13: ‘In an older woman I probably would go a bit
deeper because they’re more likely to have an
adenocarcinoma than squames.’
04: ‘The older women, 15mm, what you want to
avoid, if possible, is the inconvenience of bringing
them back for a repeat LLETZ and risking non-
attendance.’
Conditions of clinical uncertainty can cause anxiety in
both health care providers and patients. The use of ra-
tional judgements and Colposcopist’s experience appears
to aid in decision-making but affect appears to play a
strong (and sometimes more dominant) role when
evaluating risk. The following quote most accurately
reflected the overall findings of this study:
03: ‘I think it’s interesting. I think what we’re all
talking about is individualisation of care . . . All you’re
trying to do is be safe to gain or achieve the
information that you need and it does need to be
individualised. And I think in our day to day practice
that’s what we all spend our lives doing.’
Discussion
Excisional treatments have helped reduce the overall mor-
tality rate from cervical cancer by 60% in the UK [17] but
the benefits of treatment have to be tempered with the as-
sociated morbidity. Women with unsatisfactory colpos-
copy and low-grade cytology have higher than desired
treatment rates [6] and it is therefore important to explore
factors which may influence decision-making in this co-
hort. This paper addresses an important issue – the ways
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in which medical practitioners, in this case Colposcopists,
make decisions under conditions of uncertainty. A qualita-
tive approach sheds a useful light on the process of
decision-making and to the best of our knowledge this is
the first study which addresses this issue. Where rational
judgement, cognition and affect could be applied, areas of
consensus were identified; A multidisciplinary team deci-
sion, patient preference, a high-risk screening result or a
low-risk result in combination with patient risk factors such
as poor compliance, smoking, high parity or older age
resulted in recommendations for excisional treatments. In
areas of clinical uncertainty Colposcopist’s experience,
knowledge, rational judgement, perception and affect influ-
enced decision-making. When faced with an inability to
provide colposcopic assessment or diagnostic histology the
psychological stress of missing a cancer, even in women
with low-grade screening, deterred prolonged or commu-
nity based cytological follow-up. A paucity of guidance and
patient anxiety further compounded decision-making and
led to heterogeneity in care.
Decision-making is a complex process which incorpo-
rates knowledge, risk assessment, analytical skills, prior ex-
perience and affect [25]. Decision-making can be
challenging in areas of clinical uncertainty where guidance
is sparse [26, 27], when an adverse outcome such as a can-
cer may occur as a result of the decision [28] or if a large
number of variables need to be contemplated when making
a decision [26].
These themes were illustrated in our study when partici-
pants, particularly Gynaecological Oncologists, suggested
that the possibility of removing high grade disease out-
weighed the risk of treatment-related morbidity in women
with significant risk factors. In women with low-grade
cervical screening, the TOMBOLA study [29] advocates a
policy of surveillance rather than immediate treatment to
allow regression of pre-invasive disease. This policy how-
ever relies on colposcopic visualisation and histological
confirmation of the lesion, which cannot be undertaken in
women with unsatisfactory colposcopy. Whilst conscious of
the risk of over-treatment, particularly in younger women,
participants were more concerned about missing a develop-
ing cancer. This finding is supported by studies which have
shown that in areas of uncertainty, decisions are made
faster and more easily by relying on emotion [30]. Further-
more, when an emotive thought, such as fear of missing a
cancer, induces anxiety, this can lead individuals to place
more weight on the negative outcomes than the positive
[31, 32]. Once distracted by a negative stimulus it is then
difficult to divert attention from these negative thoughts
[33]. Anxiety has been associated with increased amygdala
and reduced pre-frontal activity [34] which suggests that in
areas of uncertainty affective components of decision-
making may take precedence over rational cognitive ele-
ments [35, 36].
In our study, uncertainty of decision-making in women
with low-grade cytology was reduced by the perceived
increase in risk that a persistent HPV result conferred.
However, recent evidence has shown that the proportion of
women with a low-grade screening result and subsequent
grades of pre-cancerous disease (CIN 1, 2 or 3) is no differ-
ent following the introduction of HPV testing [3]. What
has fallen is the number of women referred to colposcopy
with inadequate or borderline results and those with
normal colposcopy [3]. This could be falsely viewed as an
increase in individual risk, leading to a more aggressive
management approach when histological selection for treat-
ment is not possible. Most people are naturally risk adverse
and look to avoid poor outcomes by selecting the least risky
option [37]. Uncertainty of outcome (inability to visualise
the transformation zone) heightens anxiety and compounds
this risk aversion. When it is not clear whether the alterna-
tive decision may result in further risk or benefit, willing-
ness to take a risk, in this case prolonged cytological
follow-up, is avoided [38]. National guidance on the risk
conferred by a HPV result in women with low-grade
screening may reduce the dominant role of affect and
strengthen the cognitive component of decision-making.
Moreover, studies which assess the benefit of HPV genotyp-
ing in this cohort may also assist in risk stratification as the
10-year incidence of CIN3 is 17% with HPV 16, 14% with
HPV 18 and 3% with other high-risk subtypes [39].
The study group identified discrepancies in the recom-
mended technique and setting of cytological follow-up.
Colposcopy nurses preferred community follow-up and
this may be a reflection of the higher volume of patients
they see. Whereas the majority of Doctors favoured col-
poscopy follow-up and this attitude may be influenced
by the higher proportion of women with cervical cancer
they manage. Although current evidence suggests an in-
creased cytological yield when using a cytobrush in com-
bination with a Cervex-Brush (which samples cells from
inside and outside of the cervix) [40], there is a paucity
of evidence correlating this increased yield of cells when
used in conjunction with unsatisfactory colposcopy [41].
This lack of knowledge and the inability of community
services to offer a cytobrush compounded decision-
making, particularly for doctors. Studies which improve
knowledge in this area may aid rational judgement.
Patient choice was cited as a major influence affecting
decision-making. Eighty one percent of referrals to colpos-
copy are for low-grade screening results [3] but patients re-
port the same level of anxiety irrespective of the cytological
grade [14]. This anxiety is driven by fear of cancer, worries
that subsequent cytology will be abnormal and future
fertility concerns [14, 42]. There is a plethora of literature
assessing women’s preferences for the management of low-
grade cytology when colposcopy is satisfactory, with the
majority of studies showing a preference for colposcopic
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review over cytological (cervical smear) surveillance
[43, 44]. Furthermore, if cytological follow-up is chosen,
women have cited a preference for ‘regular’ screening [45].
Until such time as one outcome is shown to be superior to
another it could be argued that Colposcopists should advo-
cate the more cost-effective approach of cytological follow-
up. However, in a shared care model, determining patient
preferences will improve patient satisfaction and outcomes
[46] – even if this involves, as shown in our study, young
women with low-grade screening and low risk factors
choosing excisional treatments over cytological follow-up.
To reduce the emotional burden of decision-making,
health care providers will defer decision-making [47] and
the majority of our participants felt a reduction in emo-
tional burden following an MDT decision to offer excision,
particularly in young and/or nulliparous women. This find-
ing is supported by studies which have shown that the use
of the MDT reduces overtreatment in the colposcopy
setting [48] and potential heterogeneity in care. Although
it should be noted, that with a paucity of evidence to guide
this expert body’s management, homogeneity of care may
be achieved within departments or regions but may not
occur at a national level.
In areas that lack evidence it is clear that prior expertise
forms the basis of decision-making [49]. This was evident
when participants recommended a depth of excision
which was incongruent with recent national guidance [7].
Furthermore, experienced Colposcopists were more likely
to recommend longer total length of conservative follow-
up and at 12 month intervals in women with low-grade
screening. Evidence has suggested that experts are ‘wise
risk takers’ [50], their knowledge reduces anxiety and
indecision allowing them to make decisions which deviate
from set guidance to individualise care [51].
Colposcopists are independent practitioners and it could
be argued that guidance may not be necessary in scenarios
which lack consensus of opinion. Furthermore, it is clear
that not all clinical scenarios can conform to guidance and
removing all uncertainty from the medical profession may
hinder adaptability, critical analysis, maturity of thought and
patient choice. That being said, part of a clinicians’ duty is
to reduce patient anxiety and optimise clinical outcomes,
but how can this be achieved if the clinician themselves is
plagued by anxiety. In situations where there is a lack of
clear evidence, affect may compromise rational judgements.
Homogeneity of care improves service provision and clinical
outcomes through consistent use of evidenced based inter-
ventions [52] and the majority of decisions in colposcopy
contain a small number of variables and are fairly unam-
biguous. Guidelines improve decision-making in areas of
ambiguity, recognize shortfalls in the literature, provide
assurance that clinicians are advocating appropriate treat-
ments and promote under-recognised and neglected patient
cohorts.
This study had some limitations. Assessing practice in
one geographical UK region may increase the institutional
bias but the inclusion of four centres with varying patient
populations and participants who trained in different
regions improved the generalizability of the data. Moreover,
there was no difference in opinion based on training loca-
tion. To triangulate these findings we propose a nationwide
survey, based on the themes identified, to explore the
frequency of these opinions and identify areas of consensus
where guidance may be clarified. It is also important to
consider why participants agreed to take part; it could be
argued that attendees did so to express a particular view-
point and therefore the data may not resonate with national
opinions. However, only four of twenty eight Colposcopists
did not participate and this was due to conflicting clinical
commitments. Furthermore, two of these gave written
statements for clinical scenarios that they wished to be
discussed. Although these statements were not used in the
analysis, they stimulated animated discussions on the opti-
mal cytology collection device and the risks and benefits of
repeating the referral cytology at the first Colposcopy
appointment.
Age and gender were not collected for confidentiality
reasons. However, gender has been shown to influence
clinical decision-making. Female clinicians can have lon-
ger consultation times with more time devoted to counsel-
ling [53] whereas male colleagues may spend more time
discussing technical aspects [54]. As a key outcome of this
study was factors affecting choice of conservative or surgi-
cal management, assessing this association would be use-
ful for guideline implementation and should be explored
in future studies such as a national survey. Correlation of
experience with management decisions may also be valu-
able for guideline development and it could be argued that
more weight should be applied to recommendations from
Colposcopists who have more experience in this area.
However, measuring competence and experience can be
problematic; most decision-making in Colposcopy contains
limited variables and is formulaic, all Colposcopists have to
attain the same basic competencies and re-accredit three
yearly. Therefore a consensus opinion may provide best
recommendations for guidance and in areas of dissonance,
further research will be required to aid analytical thinking
and reduce uncertainty.
Focus groups, rather than interviews or questionnaires,
were chosen as the method of study as numerous view-
points on a specific issue can be studied in an interactive
setting and comments made by individual participants stim-
ulated group discussions. The use of focus groups reduced
the interaction of the facilitator and the input or potential
bias of the researchers. Moreover, they provided richer data
than a questionnaire by expanding upon the decision-
making process and enabling targeted suggestions for guid-
ance which was the key component of interest in this study.
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Block sampling was chosen as it can be more repre-
sentative; a heterogenous group ensured differing
opinions were shared leading to lively debates in
some of the units. Sensitization, with the possibility
of pre-set answers which may reduce analytical think-
ing during the focus groups, was reduced by the
provision of a general theme in the participant infor-
mation sheet rather than set questions. Further
strengths included the use of open ended questions,
an extensive coding process and an iterative analysis
which helped ensure saturation and depth of informa-
tion was attained. Transcription of the data by KM
facilitated reading and interpretation of the data as
suggested by Braun and Clarke. None of the partici-
pants withdrew their data and the respondents veri-
fied the validity of the transcripts. The interpretivist
method of data collection, the heterogenous group,
double coding of the transcripts and a self-awareness
of the researchers own preconceptions by including
both Colposcopists and qualitative researchers in the
study group will have reduced reflexitivity [55].
Conclusions
We would argue that in order for experts to analyse infor-
mation they utilise cognition as well as the emotional im-
pact from their past experiences. However, in areas of
clinical uncertainty when decisions are dominated by
emotive factors, clinical guidance can reduce the difficulty
and anxiety of decision-making. Colposcopists’ opinions
and experiences are likely to have a significant effect on
national policy and the implementation of guidelines in a
clinical setting. In our study, clear areas of consensus in-
cluded use of the multidisciplinary team and offering exci-
sion to women with high-grade cytology and high risk
women with low-grade cytology such as smokers, non-
attenders, parous and older women. Areas of dissonance,
which were affected by paucity of evidence and anxiety of
missing a cancer, deterred long-term conservative follow-
up and promoted repetition of the referral cytology and
higher than desired treatment rates in women with low-
grade screening.
Future research should focus on a nationwide survey to
explore the frequency of opinions identified in this study,
assessment of the optimal cytological collection device for
a transformation zone type 3, including efficacy of primary
care sampling in this cohort. Prospective studies which
assess the progression rate of pre-cancerous change in
women with low-grade cytology to inform interval lengths
in women who are managed with cytological follow-up,
evaluation of patient decision-making and techniques that
improve the PPV of screening in this cohort such as bio-
markers that detect HPV-transforming infection, HPV
genotyping and techniques which sample an endocervical
transformation zone.
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